Hims Enhances Drug Production with Strategic Acquisition of California Peptide Facility

Hims, a prominent player in the telehealth and pharmaceutical sector, has made a significant move to bolster its drug manufacturing capabilities by acquiring a peptide manufacturing plant in California. This strategic acquisition aligns with the company’s ongoing efforts to expand its product offerings and maintain a competitive edge in the industry.

Continue reading